AMP is a non-profit continuing-education organisation. All of AMP’s activities are 100% funded by subscribers.
No grants
Prescrire does not depend on any financial or other support from governmental or other institutions. Prescrire’s editors enjoy complete freedom to criticise the practices, policies and prejudices of regulatory agencies and other authorities, be they French, European or international. This includes:
- Detailed analyses of the guidelines published by France’s national health authority, exposing incomplete information, conflicts of interest and other breaches of the public trust;
- Several well-documented complaints against the European Medicines Agency’s repeated refusals to comply with Prescrire’s requests for information on adverse effects;
- Criticism of the World Health Organization and other international bodies for their flawed recommendations, conflicts of interest and institutional biases.
No advertising
Prescrire accepts no advertising and does not depend in any way, shape or form on support from industry. Prescrire does not publish sponsored sections or supplements. Prescrire does not offer bulk subscriptions paid for by pharmaceutical companies. We do not make money on reprints. Prescrire and its editors do not accept fees, gifts, invitations, travel or other perks from industry. Hence Prescrire is free to publish frank, fair appraisals of products as well as policies.
No conflicts of interest
Every text published in Prescrire (with a very few exceptions, such as readers’ letters, which are clearly identified as such) is produced entirely by Prescrire’s Editorial Staff. And every year, each and every member of Prescrire’s Editorial Staff is required to sign a declaration of absence of conflicts of interests. The members and managers of Association Mieux Prescrire sign the same declaration. This ensures that Prescrire and Prescrire International remain entirely free of undue influence.
©Prescrire 1 May 2012
"No grants. No advertising. No conflicts of interest." Prescrire Int 2012; 21 (126): iv. (Pdf, free).